Meet ApplyKite Twin, the application assistant that learns with you
Meet your Twin, it learns with you
Your Twin learns with you
Launch week codes:30% off annual Pro20% off monthly Pro
Ends in00h00m00s
Ends in00h00m00s
US Food and Drug Administration
3 days ago
FDA Regulatory Analysis of Dose-Finding and Optimization Approaches in Targeted Oncology Therapeutics U.S. Food and Drug Administration (FDA) in United States
Degree Level
Master's
Field of study
Biology
Funding
Monthly stipend commensurate with educational level and experience; appointment initially for one year and may be renewed subject to FDA recommendation and availability of funds.
Deadline
Nov 27, 2026
Country
United States
University
US Food and Drug Administration
Apply for this position
Keywords
Suggested positions
About this position
This research opportunity at the U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER) focuses on how dose selection and optimization are being used in targeted oncology therapeutics, including drugs such as tyrosine kinase inhibitors. The project is set within the FDA’s regulatory science environment in White Oak, Maryland, where CDER evaluates the safety and effectiveness of drugs used in the United States.
The participant will work on a project that collects and analyzes dose-finding and dose-optimization strategies from recently approved and investigational oncology products. The research draws on regulatory documents and review materials for New Drug Applications, Biologics License Applications, and active Investigational New Drug applications, with attention to study design, dose-limiting toxicities, recommended Phase 2 dose, maximum tolerated or administrated dose, randomized dosage optimization, pharmacokinetic and pharmacodynamic characteristics, and exposure-response relationships.
The role includes synthesizing large datasets to identify trends, patterns, and challenges in oncology dose selection and preparing findings for discussion with FDA clinical pharmacology staff and Division of Cancer Pharmacology leadership. The participant will also contribute to a manuscript and present results to a clinical pharmacology audience, gaining experience in regulatory decision-making and policy-relevant clinical pharmacology research.
The mentor for this opportunity is Siyan Zhu at FDA CDER.
Funding details
Monthly stipend commensurate with educational level and experience; appointment initially for one year and may be renewed subject to FDA recommendation and availability of funds.
What's required
The qualified candidate should be currently pursuing or have received a master's or doctoral degree in a relevant field. Applicants must be able to provide an application, transcripts, a current resume/CV, and one educational or professional recommendation. All documents must be in English or include an official English translation. U.S. citizenship, lawful permanent resident status, or an acceptable non-U.S. citizen immigration status is required, and applicants must satisfy the background investigation residency requirement of having lived in the United States for a total of three of the past five years. Proof of health insurance is required for participation.
How to apply
Submit the application through the Zintellect portal by clicking APPLY at the bottom of the opportunity page. Include transcripts, a current resume/CV, and one recommendation. If you have questions, email [email protected] and include the reference code FDA-CDER-2026-0183.
Make your next move.
Prepare your application
Review drafts and confirm requirements with the university.
Make your next move.
Prepare your application
Review drafts and confirm requirements with the university.